...-invasive respiratory support Nutrition Oxygen supplementation Patent ductus arteriosus Preterm infant Respiratory distress syndrome Surfactant therapy Thermoregulation Survival of preterm infants continues to improve, with those at 22–23 weeks of gestation now having reasonable chances...

.... The combination of oxygen, nasal continuous positive airway pressure (CPAP) and surfactant therapy has the potential to prevent 42% of RDS-related deaths in sub-Saharan Africa, despite the financial implications. This article provides a brief overview on the status of RDS management, mainly nasal CPAP...

... syndrome Surfactant therapy Thermoregulation Respiratory distress syndrome (RDS) remains a significant problem for preterm babies, although management has evolved gradually over the years resulting in improved survival for the smallest infants but with unacceptable rates of bronchopulmonary...

... practice Hyaline membrane disease Mechanical ventilation Nutrition Oxygen supplementation Patent ductus arteriosus Preterm infant Respiratory distress syndrome Surfactant therapy Thermoregulation Respiratory distress syndrome (RDS) remains a significant problem for preterm babies although...

... ventilation Oxygen supplementation Patent ductus arteriosus Preterm infant Respiratory distress syndrome Surfactant therapy Thermoregulation Following surfactant administration there may, after a variable period of time, be a need for a further dose of surfactant. In randomized trials 2 doses...

.... Antenatal steroids Continuous positive airway pressure Evidence-based practice Mechanical ventilation Oxygen supplementation Patent ductus arteriosus Respiratory distress syndrome Surfactant therapy Thermoregulation formerly Biology of the Neonate Consensus Guidelines Neonatology 2010;97:402 417...

... findings of structural, biochemical and functional pulmonary immaturity in CDH is reviewed. Prenatal administration of corticosteroids to accelerate fetal pulmonary maturation, and the use of early surfactant therapy, should be further evaluated in the clinical management of CDH. 30 9 2009...

... as a crucial layer of protection against a vast array of pathogens that escape the physical barriers and threaten to infect the delicate respiratory epithelium. An important clinical application may be the inhalation, or instillation of collectin-based drugs as part of surfactant therapy, to prevent and treat...